Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo
about
Why prevent, diagnose and treat congenital toxoplasmosis?T. gondii RP promoters & knockdown reveal molecular pathways associated with proliferation and cell-cycle arrestRapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii.Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.A small molecule that binds and inhibits the ETV1 transcription factor oncoproteinNovel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway.New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections.Donor CD8+ T cells prevent Toxoplasma gondii de-encystation but fail to rescue the exhausted endogenous CD8+ T cell population.Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.Phenotypic and gene expression changes among clonal type I strains of Toxoplasma gondii.A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016).Drugs in development for toxoplasmosis: advances, challenges, and current status.Spiroindolone that inhibits PfATPase4 is a potent, cidal inhibitor of Toxoplasma gondii tachyzoites in vitro and in vivoSimple and efficient model systems of screening anti-Toxoplasma drugs in vitro.Therapy for ocular toxoplasmosis--the future.Recent advances in Toxoplasma gondii immunotherapeutics.Discovery of Potent and Selective Leads against Toxoplasma gondii Dihydrofolate Reductase via Structure-Based Design.Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives.In vitro activity of JPC 2067 alone and in combination with sulfamethoxazole against nocardia speciesCongenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years.
P2860
Q22305913-C7186B09-F3A6-4B83-AB2D-AF7070AD40EFQ27316417-CAA502FF-6393-4C45-88C3-1D73EE4B6A98Q33832248-1A0D7D12-BA19-4BD1-B030-92C4587A538CQ33833620-1C4D2BAC-DC60-4024-B84D-F2EDAEE1ACEBQ34043532-5F53A2BA-2556-479E-B6CF-E745553CDF63Q34132931-930C6C3A-3D04-4146-8C38-B19C8A1D1FBEQ35941319-FD355581-8FF2-4A63-A321-62D038AB1D4FQ37093155-AB82271C-668F-4395-BA05-3034348F6D9AQ37123725-3CEB7E6F-D3EC-42D3-A7AB-61DA9D338030Q37128281-E9C0772B-AF1A-41CE-BA13-B79076DB2C4FQ37428599-E208996C-28C6-4479-A0D4-82C166DEAC00Q37477708-1391CB31-1965-419C-BECE-8F0CE80FF439Q37594988-801549F3-CDFE-4AC3-8F19-A5AA43A15EEDQ37613765-824B7222-076D-42A8-B1CC-8B660DF88663Q37643652-D688B83D-B318-4605-891A-507FD9225D60Q37999103-DC67F87A-F23D-4BA1-8CD9-B0BE03D4672AQ38101597-EBA98486-5A51-4D02-83BF-1071A531329AQ38303517-4F35C597-B64A-4408-9788-644232E76EB1Q39085479-211ECDDB-93CE-4617-87A0-D6077DAC7656Q40201110-DCEE22ED-0201-410C-BE24-AB95E84102A6Q40600667-6061D54F-40E1-40AE-8E1F-569EA00B4BB3Q42277120-BF7CB4E2-7A0A-46DF-B840-0071C2FDD443
P2860
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo
@ast
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo
@en
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo
@en-gb
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo
@nl
type
label
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo
@ast
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo
@en
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo
@en-gb
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo
@nl
altLabel
Novel Triazine JPC-2067-B Inhibits Toxoplasma gondii In Vitro and In Vivo
@en
prefLabel
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo
@ast
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo
@en
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo
@en-gb
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo
@nl
P2093
P2860
P50
P3181
P1476
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo
@en
P2093
David P Jacobus
David Rice
Ernest J Mui
Guy A Schiehser
Honghue Hsu
Joseph W Fowble
Michael Kirisits
Pradipsinh K Rathod
Rima McLeod
Sherry F Queener
P2860
P3181
P356
10.1371/JOURNAL.PNTD.0000190
P407
P577
2008-01-01T00:00:00Z